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Virosomes are reconstituted viral envelopes that can serve as vaccines and as vehicles for cellular delivery of various macromolecules. To
further advance the use of virosomes, we developed a novel dialysis procedure for the reconstitution of influenza virus membranes that is easily
applicable to industrial production and compatible with encapsulation of a variety of compounds. This procedure relies on the use of 1,2-
dicaproyl-sn-glycero-3-phosphocholine (DCPC) as a solubilizing agent. DCPC is a short-chain lecithin with detergent-like properties and with a
critical micelle concentration of 14 mM. DCPC effectively dissolved the influenza virus membranes after which the nucleocapsids could be
removed by ultracentrifugation. The solubilized membrane components were reconstituted either by removal of DCPC by dialysis or by a
procedure involving initial dilution of the solubilized membrane components followed by dialysis. Both protocols resulted in removal of 99.9% of
DCPC and simultaneous formation of virosomes. Analysis of the virosome preparations by equilibrium sucrose density gradient centrifugation
revealed co-migration of phospholipid and protein for virosomes produced by either method. Moreover, both virosome preparations showed
morphological and fusogenic characteristics similar to native influenza virus. Size, homogeneity and spike density of the virosomes varied with
the two different reconstitution procedures employed. The recovery of viral membrane proteins and phospholipids in the virosomes was found to
be higher for the dilution/dialysis procedure than for the simple dialysis protocol. This novel procedure for the production of virosomes is
straightforward and robust and allows further exploitation of virosomes as vaccines or as drug delivery vehicles not only in academia, but also in
industrial settings.
© 2006 Elsevier B.V. All rights reserved.Keywords: Short-chain lecithin; Dialysis; Reconstitution; Influenza virus; Virosome1. Introduction
Virosomes are reconstituted viral envelopes composed of
membrane lipids and viral spike glycoproteins but devoid of
viral DNA or RNA. The external surface of virosomes
resembles that of virus particles with the spike proteins
protruding from the membrane while the lumen of virosomes
is empty. Virosomes were first described by Almeida et al. by
insertion of purified spike proteins of the influenza virus into
pre-formed liposomes [1]. Thereafter, reconstitution of a range
of viral envelopes has been achieved including those of Sendai⁎ Corresponding author. Tel.: +31 50 3632714; fax: +31 50 3638171.
E-mail address: a.l.w.huckriede@med.umcg.nl (A. Huckriede).
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doi:10.1016/j.bbamem.2006.03.011virus [2–4], Semliki Forest virus (SFV, [5,6]), vesicular
stomatitis virus (VSV, [7,8]) and Sindbis virus [9]. Since
virosomes are virus-like particles, which display the viral
envelope glycoproteins and thus the most important viral
antigens for humoral immune responses in a native configura-
tion, they are highly suitable for use as vaccines [10–12].
Moreover, the receptor binding and membrane fusion properties
of the viral envelope glycoprotein can be preserved which
allows the use of virosomes as transport vehicles for cellular
delivery of biologically active macromolecules (reviewed in:
[13–16]).
Influenza virus is one of the viruses most commonly used for
virosome production. It possesses two envelope glycoproteins;
hemagglutinin (HA) and neuraminidase (NA). HA, the major
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fusion, while NA is involved in virus budding. HA is a class I
fusion protein and associates into trimers. HA0, the precursor of
HA, is cleaved into HA1 and HA2, which are linked by two
disulfide bonds. When influenza encounters a target cell, HA1
binds to sialic acid residues on the surface of the cell, after which,
the virus enters the endocytic pathway. The mildly acidic pH in
the endosome induces a conformational change in HA. Thereby,
the N-terminal fusion peptide of HA2, previously buried in the
stem of the HA trimer, is exposed and inserted into the endosomal
membrane. Subsequently, the protein refolds into a hairpin
structure, which brings the viral membrane and the target mem-
brane into close proximity thereby inducing fusion. Through the
merging of the two membranes, the viral nucleocapsid containing
the genetic material is released into the cytoplasm [17–21].
A prerequisite for successful use of virosomes as vaccines or as
delivery vehicles is reconstitution of the membrane proteins such
that their immunogenic properties and receptor binding and
membrane fusion activities are retained. Previously, we have
developed a method for the functional reconstitution of influenza
virus membranes [22]. This method is based on solubilization of
the viral membrane by the detergent octaethyleneglycol mono(n-
dodecyl)ether (C12E8). After the solubilization step, the nucleo-
capsid of the virus is removed by ultracentrifugation and
reconstitution of the viral membranes is accomplished by removal
of C12E8 through adsorption onto a hydrophobic resin (Bio-Beads
SM-2). Virosomes produced by this method fuse in a pH-
dependent manner similar to native influenza virus [22].
Successful delivery of virosome-encapsulated proteins to target
cells in vitro was demonstrated for gelonin [23], subunit A of
diphtheria toxin [24] and ovalbumin [25]. Moreover, when
cationic lipids were added prior to membrane reconstitution,
virosomes proved suitable for binding/encapsulation ofDNA [26]
or siRNA [27] and subsequent delivery of these nucleic acids. In
all cases, inhibition of HA-mediated fusion completely abolished
delivery, indicating that virosomes indeed exploit the viral fusion
mechanisms to transport their cargo to the target cell cytosol.
Virosomes are also suitable for delivery of encapsulated
macromolecules in vivo as was demonstrated by immunisation
of mice with antigen-containing virosomes. Administration of
virosomes containing peptides derived from the influenza nu-
cleoprotein or intact ovalbumin induced strong cytotoxic T
lymphocyte responses against the respective antigens indicating
that the encapsulated peptides and proteins gained access to the
cytosol and the MHC class I presentation route of antigen-
presenting cells [28,29].
Although the C12E8 method is very useful for the production
of virosomes, it suffers from some inherent drawbacks.
Production according to this method, involves batch processes,
often in open systems. This is a challenging situation for in-
dustrial processing and requires special attention to obtain and
maintain sterility. Moreover, in case virosomes are used as
transport vehicles, compounds to be encapsulated could be ad-
sorbed to or inactivated by the hydrophobic resin [24]. Appli-
cation of dialysis as a means of detergent removal circumvents
the above mentioned complications, since it would avoid the use
of Bio-Beads while dialysis is also up-scalable and applicable ina closed continuous process, for example, by the use of
ultrafiltration.
Efficient detergent removal by dialysis requires the use of a
detergent with a relatively high critical micelle concentration (c.
m.c.). Detergents commonly used for reconstitution of mem-
brane proteins like C12E8 and Triton X-100 have low c.m.c.s
(<1 mM) and are, therefore, not suitable. A detergent with a
high c.m.c. that has been applied frequently is octylglucoside
(OG), which has a c.m.c. of approximately 25 mM. Previous
attempts to reconstitute the influenza virus envelope using OG,
however, have failed [22]. Similar efforts with 3-[(3-cholami-
dopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS),
cholate and deoxycholate did not result in the formation of
fusion-active virosomes either.
Short-chain lecithins represent a class of amphiphilic
molecules that exhibit detergent-like properties ([30], reviewed
in: [31]). The dispersing power of short-chain lecithins was first
observed by Gabriel and colleagues in 1984 [32]. Later, the
short-chain lecithin 1,2-diheptanoyl-sn-glycero-3-phosphocho-
line (DHPC) was used in a series of studies on the reconstitution
of a variety of integral membrane proteins, such as the D-
glucose cotransporter, sucrase-isomaltase, Ca2+-ATPase and a
cholesterol transporter into proteoliposomes [33–36]. Kessi et
al. [33] and Shivanna and Rowe [34] have shown that DHPC is
superior to conventional detergents in preserving enzyme
activity. Furthermore, activity seemed unimpaired over a
broad range of DHPC concentrations. However, since DHPC
has a relatively low c.m.c. (2 mM), it is not easily removed by
dialysis. As the c.m.c. increases with decreasing chain length
[30], we hypothesized that the short-chain lecithin 1,2-
dicaproyl-sn-glycero-3-phosphocholine (DCPC), with a chain
length of six carbon atoms and a c.m.c. of 14 mM, would be
appropriate for the reconstitution of membrane proteins by
dialysis.
In this report, we demonstrate that DCPC is suitable for the
solubilization of influenza virus membranes and that it is almost
completely removed by dialysis. Two reconstitution procedures
are presented in which the rate of DCPC removal is varied. Both
methods result in the generation of virosomes with morpholog-
ical characteristics and fusogenic properties similar to those of
influenza virus. Yet, the removal rate influences size, homoge-
neity and spike density of the virosomes. Moreover, upon re-
constitution using the fast detergent removal protocol, we
observed higher protein and phospholipid recoveries than after
reconstitution by a slow detergent removal procedure. Recon-
stitution of the influenza virus envelope from DCPC-solubilized
viral membranes by means of dialysis is efficacious and com-
patible with virosome production on industrial scale. This new
procedure may facilitate the production of virosomal vaccines
and stimulate the use of virosomes for cellular delivery purposes.2. Materials and methods
2.1. Materials
DCPC was obtained from Avanti Polar Lipids, Inc (Alabaster, Alabama,
USA). 1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphocholine
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Lyzers, all with a molecular weight cut off (MWCO) of 10 kDa, were obtained
from Pierce (Rockford, Illinois, USA). Influenza virus (A/Panama/2007/99
(H3N2)) was kindly provided by Solvay Pharmaceuticals B.V. (Weesp, The
Netherlands).2.2. Virus inactivation
Where indicated influenza virus was inactivated by β-propiolactone (BPL
98%; Acros Organics, Geel, Belgium) treatment prior to virosome
preparation. For this purpose, BPL was added to the virus suspension
(1.78 μmol/mL viral phospholipids in 125 mM Na-citrate, 35–47% sucrose
(w/w), pH 7.3–8.0) at a final dilution of 1:1000 (v/v). The virus suspension
was incubated for 24 h with gentle mixing in the dark at room temperature.
Residual BPL was removed by dialysis against HEPES-buffered saline (HBS;
5 mM HEPES, 0.15 M NaCl, pH 7.4) overnight at 4 °C. Alternatively,
influenza virus was inactivated by treatment with formaldehyde (0.02% (w/v)
final concentration) overnight at 4 °C.2.3. Reconstitution of virosomes
Influenza virus (1.5 μmol membrane phospholipid) was sedimented by
ultracentrifugation (100,000×g for 1 h at 4 °C) and the virus pellet was
resuspended in 375 μl HBS with a 1 ml syringe equipped with a 25-gauge
needle. The viral membrane was dissolved by addition of 375 μl 200 mMDCPC
in HBS. The suspension was incubated on ice for 30 min and the nucleocapsid
was pelleted by ultracentrifugation (100,000×g for 30 min at 4 °C). Recon-
stitution of the virus membrane was accomplished by removal of DCPC by
means of dialysis. Two reconstitution procedures were applied, varying in the
rate of detergent removal. In the course of the first procedure, the supernatant
containing the viral lipids and membrane proteins was dialyzed against 2 L of
HBS overnight at 4 °C in a 0.5–3 ml Slide-A-Lyzer. The buffer was exchanged
once and the supernatant was dialyzed for another 4 h. This method is referred to
as ‘slow reconstitution’. In the second procedure, the supernatant containing the
viral lipids and membrane proteins was instantly diluted 5 times with HBS to
reach a DCPC concentration of 20 mM (c.m.c. of DCPC: 14 mM). The diluted
mixture was then dialyzed as described above. This procedure is referred to as
‘fast reconstitution’.
After dialysis the preparations (termed ‘crude virosome preparation’) were
applied to a discontinuous sucrose gradient (10%/50% w/v sucrose in HBS) and
centrifuged for 1.5 h (100,000×g at 4 °C) to separate non-incorporated material
from the reconstituted virus membranes. The final preparations (termed ‘purified
virosome preparation’) were recovered from the interface of the two sucrose
layers, transferred to a 0.1–0.5 ml Slide-A-Lyzer and dialyzed against 2 L HBS
overnight at 4 °C to remove the sucrose.Fig. 1. Efficiency of virus solubilization by DCPC. Influenza virus (2 mM viral
lipid) was treated with increasing concentrations of DCPC. Non-solubilized
material was removed by ultracentrifugation and the dissolved virus components
(supernatant) were subjected to analysis. (A) Protein content (% of total viral
protein) of the supernatant after solubilization at the indicated concentrations of
DCPC. (B) SDS-PAGE analysis of the solubilized proteins. Under the non-
reducing conditions primarily HA is visible, however, traces of HA1 and HA2
were also detected. A/Pan, A/Panama virus; M, protein marker, figures indicate
molecular weight in kDa.2.4. Biochemical analyses
Virosomes were analyzed for protein content by a micro Lowry assay [37]
and subjected to SDS-PAGE followed by Coomassie blue staining. Phospho-
lipid content was determined by a phosphate assay [38]. Residual DCPC in the
virosomes was determined as follows: Virosomes and virus (100 nmol
phospholipid) were subjected to lipid extraction [39]. The extracted lipids
were applied onto a silica gel plate for thin-layer chromatography (TLC plate,
RP-8 F254s, Merck, Darmstadt, Germany) and eluted with a solvent mixture of
methanol:chloroform:water (10:5:4, by vol.). Phospholipids were stained using
a phosphorus spray containing 40 ml reagent 1 (20.5 g of molybdic anhydride
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany) in 500 ml concentrated
sulfuric acid), 40 ml of reagent 2 (0.89 g of molybdenum metal (Sigma-Aldrich)
in 250 ml reagent 1) and 120 ml water [40]. TLC plates were sprayed with a
mixture of the phosphorus spray:water:methanol (1:1:2, by vol.), resulting in a
better color development than using the phosphorus spray alone. The TLC plates
were scanned using a flatbed scanner and the DCPC spots were quantified using
image analysis software (Zero-Dscan, version 1.0). The DCPC content of the
virosomes was determined by comparison with DCPC calibrants.2.5. Analysis by equilibrium density centrifugation
Virosomes were analyzed for co-migration of phospholipids and protein on a
linear sucrose density gradient (10–60% sucrose (w/v) in HBS). The sucrose
gradients were centrifuged until equilibrium at 300,000×g for 65 h at 4 °C.
Fractions were analyzed for protein and phosphate content as described above.
2.6. Membrane fusion
For determination of their fusogenic properties, virosomes were labeled with
10 mol% pyrPC relative to viral phospholipids. PyrPC was dissolved in
chloroform and the required amount was dried under a stream of nitrogen gas
and kept under vacuum for 2 h to remove remaining traces of chloroform. The
supernatant containing the viral membrane lipids and proteins was added to the
dried pyrPC and incubated for 30 min at room temperature prior to
reconstitution. To study the fusion characteristics of the virosomes, fusion
assays and fusion inactivation were performed as described [25,41]. The initial
rate of fusion was determined from the slope of the fusion curve during the first
8 s after initiation of fusion.
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Virus or virosomes were dialyzed against ammonium acetate buffer (75 mM
ammonium acetate, 2.5 mM HEPES, pH 7.4) overnight at 4 °C. The virosome
suspensions were applied to glow-discharged 200 mesh grids covered with a
Formvar film. Virosomes or virus were stained with freshly prepared 3%
ammonium molybdaat, pH 7.2 and analyzed with a Philips CM 12 electron
microscope.
3. Results
3.1. Conditions for virus solubilization by DCPC
In an attempt to develop a novel method for the production of
virosomes as an alternative for the C12E8 method, with its
limitations for manufacturing and applications, we studied the
use of DCPC as a dialyzable detergent-like agent. In order to
determine optimal conditions for the solubilization of the viral
membrane, influenza virus (2 μmol of viral lipid in 1 mL) was
dissolved in buffers with increasing concentrations of DCPC.
After 30 min incubation at 4 °C, the non-solubilized material
was removed by ultracentrifugation and the supernatants were
analyzed for protein content. The protein detected in the
supernatants increased with increasing DCPC concentrations
(Fig. 1A). At DCPC concentrations of 150 mM and higher the
amount of solubilized viral protein exceeded the amount of total
membrane proteins present in the influenza virus, which is
approximately 40% of the total viral protein [42]. This excess
indicates that proteins other than membrane proteins were
dissolved under these conditions.
SDS-PAGE analysis of the supernatants revealed that under
all conditions tested HA and a protein migrating at the
molecular weight of NA/NP, most likely NA, were the major
proteins solubilized (Fig. 1B). The matrix protein M1, the
protein that is most prominent in intact virus particles, was not
detected in the supernatant fractions. Up to DCPC concentra-Table 1
Protein and phospholipid recoveries, protein-to-phospholipid ratios and densities of
Viral membrane
protein recovery (%)
Viral phospholipid
recovery (%)
Slow
reconstitution
Fast
reconstitution
Slow
reconstitution
Fast
reconst
Virus 100 a 100a 100 100
Crude virosome
preparation
81 90 84 90
Crude virosomes
peak fractions
34 (42) 52 (58) 57 (68) 64 (71
Purified virosome
preparation
38 43 41b 60b
Purified virosome
peak fraction
29 (77) 38 (89) 36 (87) 54 (90
Data refer to crude and purified virosome preparations and virosome peak fractions of
and B containing the crude virosome preparations were pooled for calculations. For
8 (Fig. 3C) and 6–8 (Fig. 3D) for the slow and fast reconstitution, respectively, wer
Numbers between brackets indicate percentage recovery with respect to phospholipi
a Based on membrane proteins (∼40% of total viral protein).
b not correct for residual DCPC.tions of 100 mM the amount of solubilized HA and NA
increased. Beyond this concentration, no significant increase in
HA/NA recovery was observed and increasing amounts of other
proteins such as the non-structural protein 2 (NS2) were
detected. Therefore, the 100 mM DCPC concentration was
chosen for the solubilization of the influenza virus membranes
in the subsequent experiments.
For the determination of the maximal amount of virus that can
be efficiently solubilized, increasing amounts of virus were
dissolved in a fixed volume of 100 mM DCPC buffer (0.5 mL)
and the supernatants were analyzed for protein content. At virus
concentrations of 1 and 2mMviral lipid, 35% of viral protein was
solubilized. A further increase in virus concentration resulted in
lower protein recovery (data not shown). Thus, 2 mM viral lipid
was the highest virus concentration at which maximal recovery of
membrane protein was obtained and this concentration was
therefore used in the subsequent experiments.
3.2. Biochemical and biophysical characterization of crude
virosome preparations
Reconstitution of the virus membrane was achieved by
removal of DCPC by dialysis from the dissolved viral
membrane components. The rate of DCPC removal was varied
by applying two different reconstitution methods. In the first
protocol, the supernatant containing the solubilized membrane
components was directly dialyzed, starting from a DCPC con-
centration of 100 mM. In this way, DCPC is gradually removed
from the mixed micelles. This method will be referred to as
‘slow reconstitution’. In the second protocol, the supernatant
containing the membrane components was diluted 5 times with
buffer prior to dialysis. This procedure reduces the DCPC
concentration instantaneously from 100 mM to 20 mM, the
latter being close to the c.m.c. of DCPC (14 mM). Con-
sequently, fast removal of DCPC from mixed micelles isvirosomes during different stages of preparation
Protein/phospholipid Average density (g/mL)
itution
Slow
reconstitution
Fast
reconstitution
Slow
reconstitution
Fast
reconstitution
2.15a 2.15a
) 0.84 1,11 1,136 1,149
) 1,07 1,16 1,140 1,145
sucrose density gradients. Peak fractions 7,8 and 9 of gradients shown in Fig. 3A
the gradients containing the purified virosome preparations, peak fractions 5–
e pooled for calculations. The data were obtained from a typical experiment.
d or protein in the virosome preparation applied to the sucrose density gradient.
Fig. 2. SDS-PAGE analysis of virosomes. Virosome preparations obtained by
the slow reconstitution procedure (S) and the fast reconstitution procedure (F)
were analyzed before (S1, F1) and after (S2, F2) purification on a discontinuous
sucrose gradient. Analysis was performed under reducing and non-reducing
conditions. A/Pan, A/Panama virus; M, protein marker, figures indicate
molecular weight in kDa.
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to as ‘fast reconstitution’.
After reconstitution of the membrane components by the
slow or the fast procedure, the ‘crude’ virosome preparationsFig. 3. Analysis by equilibrium density centrifugation. Slow reconstitution virosom
reconstitution (crude virosomes: A, B) or after purification on a discontinuous sucro
filled circles represent protein and open squares represent the density.obtained, contained approximately 80–90% of the viral
membrane proteins and viral phospholipids (Table 1). The
proteins consisted primarily of HA and small amounts of NA, as
was shown by SDS-PAGE analysis (Fig. 2, samples S1, F1).
To determine the efficiency of the two different reconstitu-
tion procedures, the crude virosome preparations were analyzed
by equilibrium centrifugation on linear sucrose density
gradients. Analysis of the preparation obtained by the slow
reconstitution procedure revealed co-migration of proteins and
phospholipids in fractions 7, 8 and 9 indicating that these
fractions contained vesicles with proteins incorporated in their
membranes (Fig. 3A). Fractions 10 and 11 contained mainly
proteins and little phospholipid. It is likely that these proteins
formed aggregates with few phospholipid molecules incorpo-
rated. Analysis of the preparation obtained by the fast
reconstitution procedure revealed overlapping protein and
phospholipid peaks again in fractions 7, 8 and 9 (Fig. 3B).
Small amounts of protein aggregates with little phospholipid
were detected in fractions 10 and 11. The recovery of proteins in
the virosome fractions 7, 8 and 9 was higher for the fast
reconstitution procedure (approximately 60%) than for the slow
reconstitution procedure (approximately 40%), while thees (A, C) and fast reconstitution virosomes (B, D) were analyzed directly after
se gradient (purified virosomes: C, D). Filled triangles represent phospholipid,
Fig. 4. Phospholipid analysis by TLC to determine residual DCPC in virosomes.
(A) 10 nmol DCPC; (B) 100 nmol A/Panama viral phospholipids; (C) 100 nmol
A/Panama viral phospholipids spiked with 10 nmol DCPC; (D) 100 nmol
phospholipids of slow reconstitution virosomes; (E) 100 nmol phospholipids of
fast reconstitution virosomes. Before elution, lipids were extracted from the
virosome or virus suspensions by the Bligh and Dyer method. Phospholipids
were visualized by a phosphate stain. Arrow indicates DCPC spots.
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methods (Table 1).3.3. Biochemical and biophysical characterization of purified
virosomes
The crude virosome preparations were purified on a
discontinuous sucrose gradient to remove non-incorporated
proteins and lipids. In a typical experiment the resulting purified
virosomes contained approximately 40% of the initial membrane
proteins for both methods and approximately 40% and 60% of
viral phospholipids for the slow and fast reconstitution proce-
dures, respectively (Table 1). SDS-PAGE analysis showed that
the amount of NA in the purified virosomes declined compared to
the crude preparations, the purified virosomes containing mainly
HA (Fig. 2, S2 vs. S1 and F2 vs. F1). Therefore, it would appear
that NA is incorporated less efficiently than HA. SDS-PAGEFig. 5. Analysis of virus and virosome preparations by negative stain transmission
(C) fast reconstitution virosomes; (D) overview of slow reconstitution virosomes and
D and E=500 nm.revealed no differences in the protein profiles of virosomes
prepared by the two different reconstitution methods.
The purified virosomes were further characterized by
equilibrium density gradient centrifugation. Generally, the
phospholipid and protein migration patterns of virosomes
produced by the slow reconstitution procedure revealed some
variability. The majority of protein and phospholipid of a typical
preparation was detected in fractions 5–8 (Fig. 3C). It appeared
that the protein aggregates, present in the crude virosome
preparation, had been removed to a large extent by the
purification step, however, traces of non-incorporated protein
were still found in fraction 10. The pooled virosome fractions
(5–8) contained vesicles with a mean density of 1.140 g/mL and
a protein-to-phospholipid ratio of 1.07 mg/μmol (Table 1).
Routinely, virosomes produced by the fast reconstitution
revealed highly reproducible phospholipid and protein migra-
tion patterns on a linear sucrose density gradient. A typical
virosome preparation showed prominent protein and phosphate
peaks in fractions 6, 7 and 8 (Fig. 3D). When pooled, these
fractions contained vesicles with a density of 1.145 g/mL and a
protein-to-phospholipid ratio of 1.16 mg/μmol (Table 1). Thus,
virosomes produced by the fast reconstitution method are more
densely packed with HA.
3.4. Determination of residual DCPC
To evaluate whether DCPC was removed efficiently by the
dialysis procedure, the DCPC content of the purified virosomes
was determined by thin layer chromatography (TLC). Using an
eluent consisting of methanol:chloroform:water (10:5:4 by vol.)
DCPC could be clearly separated from the more hydrophobic
viral lipids (Fig. 4A, B and C). Densitometric analysis of the
DCPC spots showed that slow reconstitution virosomes
contained approximately 8 nmol DCPC per 100 nmol virosomal
phospholipids and virosomes prepared by the fast reconstitution
procedure contained approximately 6 nmol DCPC (Fig. 4D and
E). Thus, residual DCPC is less than 10% of the virosomalelectron microscopy. (A) A/Panama virus; (B) slow reconstitution virosomes;
(E) overview of fast reconstitution virosomes. Bar in A, B and C=100 nm, bar in
Fig. 6. Hemagglutinin-dependent fusion of virosomes with erythrocyte ghosts.
(A) Fusion curves of slow reconstitution virosomes (1), C12E8 virosomes (2) and
fast reconstitution virosomes (3) after exposure to pH 5.5. Fusion curves of
virosomes at neutral pH (4) and after inactivation by exposure to low pH without
target membranes (5). (B) Maximal fusion at different pH values for slow
reconstitution virosomes (filled circles) and fast reconstitution virosomes (open
circles). (C) Initial fusion rates of slow reconstitution virosomes (filled circles)
and fast reconstitution virosomes (open circles).
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the dialysis protocol effectively removed more than 99.9% of
the initial amount of DCPC used for solubilization of the viral
membrane.
3.5. Electron microscopy
Virosomes produced by both reconstitution methods re-
semble native virus, as revealed by negative stain electron
microscopy (Fig. 5A–C). The preparations contained predom-
inantly vesicles densely covered with spikes protruding from
their membranes. Virosomes obtained by the slow reconstitu-
tion method and purified on a discontinuous sucrose gradient
had an average diameter of 146±64 nm, which was calculated
from 98 representative virosome particles (Fig. 5D). This
diameter is larger than the average diameter of native virus,
which is 100 nm (±20) [42]. Additionally, small protein
aggregates (rosettes) were observed likely representing the
non-incorporated proteins that were detected in the bottom
fraction of the linear sucrose density gradient (Fig. 3C).
Virosomes prepared by the fast reconstitution method resulted
in smaller and more homogenous vesicles compared to viro-
somes prepared by the slow reconstitution method (Fig. 5E).
The average diameter was calculated to be 113±20 nm
(n=116) with a size distribution narrower than that of the
slow reconstitution virosomes. Moreover, these preparations
were devoid of protein aggregates.
3.6. Fusion activity
Retention of biologically relevant fusion activity is a
prerequisite for application of virosomes as a cellular delivery
system. To measure fusion activity, a pyrene-labeled lipid was
incorporated in the virosomal membrane during the reconsti-
tution process. When incorporated, pyrene-labeled lipids form
dimers that exhibit excited-dimer (or “excimer”) fluorescence.
This excimer fluorescence intensity is dependent on the
concentration of the pyrene-labeled lipids in the membrane.
After fusion of a pyrene-labeled virosome with a substantially
larger target membrane, the excimer fluorescence decreases due
to dilution of the pyrene probe into the target membrane, which
is a direct measure for fusion. In this fusion assay, erythrocyte
ghosts were used as target membranes. When exposed to pH
5.5, virosomes prepared by the slow and fast reconstitution
procedure showed rapid fusion with erythrocyte ghosts (Fig.
6A). Maximal fusion was reached within 60 s and fusion was
strictly pH-dependent, since no fusion was observed at neutral
pH. When HAwas inactivated by pre-exposure of the virosomes
to low pH in the absence of target membranes, fusion activity
was abolished completely. These findings demonstrate that
fusion of virosomes is dependent on the conformational change
of HA induced by a decrease in pH, as described for native virus
(reviewed in: [17]). Like influenza virus [22], the virosomes
exhibited a pH optimum for fusion (Fig. 6B and C). Maximal
fusion was achieved at pH 5.6 and the fastest initial rate of
fusion was reached at pH 5.2. The difference in pH optimum for
maximal fusion and fastest initial rate of fusion is explained bythe fact that fusion is a balance between activation and
inactivation of HA induced by low pH. At lower pH values,
both fusion activation and HA inactivation increase, which may
result in a higher initial rate, but a lower final extent of fusion
[43]. Thus, virosomes produced by both reconstitution methods
fuse with the same kinetics and to approximately the same final
extent (Fig. 6B and C). Moreover, the fusion characteristics of
Fig. 7. Influence of virus inactivation on fusion activity of virosomes. Fusion at
pH 5.5 of slow reconstitution virosomes prepared from active virus (1), prepared
from BPL-inactivated virus (2) and prepared from FA-inactivated virus (3).
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those produced by the C12E8 method (Fig. 6A).
3.7. Effect of virus inactivation on virosome characteristics
While all the above experiments were carried out with
virosomes prepared from active virus, the use of inactivated
virus is a prerequisite when virosomes are to be used for medical
applications. Treatment with β-propiolactone (BPL) or formal-
dehyde (FA) are two commonly used inactivation procedures for
viruses applied in vaccine production [44,45]. Virus was
inactivated by either method and subsequently virosomes were
prepared from the inactivated virus by the DCPC dialysis
protocol. The reconstitution procedure resulted in virosomes that
accumulated on the interface of a discontinuous sucrose gradient
with protein and phospholipid recoveries comparable to the
recoveries of virosomes prepared from active virus (data not
shown). Pre-treatment of virus with BPL or FA did not affect the
fusion kinetics of virosomes generated from the inactivated virus
(Fig. 7). Moreover, virus inactivation with BPL hardly affected
the final extent of fusion of the virosomes, whereas virus
inactivation with FA reduced the final extent with approximately
25%. Thus, inactivation of virus for the production of virosomes
does not interfere with virosome yield and has a limited effect on
the fusogenic properties of virosomal HA.
4. Discussion
In this paper we report on a new procedure for the generation of
virosomes based on the use of a short-chain phospholipid with
detergent-like properties. The short-chain lecithin DCPC has a
high c.m.c. of 14 mM and is therefore suitable for removal by
dialysis. Upon solubilization of influenza virus membranes with
DCPC high amounts of HA were extracted from the virus.
Removal ofDCPC by dialysis resulted in reconstitutedmembrane
vesicles with the envelope glycoproteins inserted in the lipid
bilayer. These virosomes contained less than 0.1% of the initial
amount of DCPC, which shows that DCPC removal by dialysis is
very efficient. The size and homogeneity of the virosomes variedaccording to the reconstitution procedure applied, namely,
standard dialysis of the dissolved viral membrane components
or an initial dilution step followed by dialysis.
Importantly, the cell-binding and membrane-fusion properties
of HA were preserved in influenza virosomes prepared from
DCPC-solubilized viral membranes even when excess concentra-
tions of 200 mM DCPC were applied (data not shown). The
described method was also found suitable for the preparation of
fusion-active virosomes from Semliki Forest virus, the fusion
protein ofwhich is structurally very different fromHA (P. Schoen,
unpublished observations). These observations are in line with
findings of others that short-chain lecithins are suitable for the
solubilization of a range of different biological membranes and
preserve the functional integrity of proteins over a broad
concentration range [33,34]. In contrast, attempts to functionally
reconstitute viral membranes using OG, a frequently used
dialyzable detergent, were often unsuccessful [7,22]. If reconsti-
tution of viral membranes to fusion-active virosomes was
achieved, low concentrations of OG needed to be used and
conditions of solubilization had to be carefully controlled [46].
Reconstitution of the influenza virus membrane was achieved
by either slow removal of detergent from the mixed micelles,
accomplished by gradual dialysis (slow reconstitution method) or
by fast detergent removal, accomplished by a dilution step prior to
dialysis (fast reconstitution method). Interestingly, virosome
preparations obtained by the two procedures differed with respect
to average size and size distribution (113±20 nm vs. 146±64 nm),
as well as efficiency of HA incorporation into the lipid bilayers.
An effect of detergent removal rate on vesicle size was earlier
reported for the preparation of liposomes. As found for the
virosomes, larger liposomes were obtained when detergent
removal was slow [47–49]. According to current hypotheses,
the process of vesicle formation involves so-called disc-like
structures that are obtained when mixed micelles aggregate upon
detergent removal [47,49]. These discs slowly gain in diameter
through collision and subsequent fusion with other discs. When
the detergent becomes limiting, disc-curvature is induced, which
finally leads to vesiculation [50–53]. A fast detergent removal
rate may leave little time for the discs to fuse. Consequently, the
discs have a small surface area at the stage of vesicle closure,
which could explain the formation of small vesicles [47]. On the
other hand, when detergent is removed slowly there is more time
for collisions and fusions to take place, resulting in larger and
more heterogeneously sized discs and consequently a more
heterogeneous population of vesicles [47,49]. Our data imply that
the influence of the rate of detergent removal on vesicle size and
size distribution holds true not only for liposomes but also for
virosomes, which are much more complex systems.
With respect to the incorporation efficiency of HA into lipid
bilayers we observed that the amounts of protein and phospho-
lipid reconstituted to proper virosomes (the virosome fractions of
the linear sucrose density gradients of the ‘crude’ virosome
preparation) were higher for the fast reconstitution than for the
slow reconstitution method (Fig. 3A,B). Additionally, fast
reconstitution resulted in virosomes with higher protein to
phosphate ratios (Fig. 3C,D). Thus, fast detergent extraction
from mixed micelles obviously results in a more efficient
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confirmed by electron microscopy, which revealed that the fast
reconstitution virosome preparation consists almost entirely of
vesicles, while in the slow reconstitution preparations substantial
amounts of small protein rosettes were found (Fig. 5D,E).
Reconstitution of proteins into lipid membranes is a rather
complex process. According to the model for proteoliposome
formation as proposed by Rigaud and colleagues [54], reconsti-
tution of solubilized membrane proteins starts from a solution
containing mixed lipid–detergent and lipid–protein–detergent
micelles. For membrane proteins with a tendency to aggregate,
like HA, the model suggests that the lipid–protein–detergent
micelles are less stable than the lipid–detergent micelles and are
therefore the first to coalesce upon slow removal of detergent.
This initially results in the formation of protein-rich aggregates
and more or less protein-free liposomes into which proteins can
post-insert in a later stadium. The result would be a heterogenous
population of protein aggregates and proteoliposomes with
varying amounts of membrane-inserted proteins. In contrast,
fast detergent removal is suggested to lead to simultaneous
coalescence of lipid–detergent and lipid–protein–detergent
micelles resulting in direct co-reconstitution of lipids and proteins
into rather homogenous proteoliposomes. Our observations on
the amount of HA incorporated into lipid bilayers and the
homogeneity of the virosome preparation upon slow and fast
detergent removal, respectively, are well in line with this model.
Influenza virosomes are currently commercially used as
influenza vaccines (Inflexal V®, Berna Biotech; Invivac®, Solvay
Pharmaceuticals) and as a carrier in aHepatitis Avaccine (Epaxal®,
Berna Biotech). Techniques for the use of virosomes for the
delivery of drugs, proteins, plasmid DNA and siRNA are being
developed and commercial application of virosomes for these
purposes are being investigated. Considering these applications, the
production of virosomes by detergent dialysis has several
advantages as compared to the production by detergent removal
by adsorption to a hydrophobic resin. Detergent dialysis is up-
scalable and can be performed reproducibly by applying ‘controlled
dialysis’ or ultrafiltration [48,55,56]. Ultrafiltration can be
performed as a continuous process, which is convenient for
industrial production. By applying dialysis, the use of substances
like Bio-Beads that have to be added during the production process
and withdrawn from the final product is avoided. This simplifies
the process and prevents undesired interactions between the
hydrophobic resin and the compounds to be encapsulated. Thus,
combining the advantages of DCPC as a solubilizing agent with the
gentle removal by dialysis, a novel approach to reconstitute viral
membranes could be developed. Compared to the previously
reported C12E8 method [22], this approach is a significant
improvement for the production of virosomes, which will further
advance the clinical use of virosomes as vaccines on the one hand
and as drug delivery vehicles on the other hand.
Acknowledgements
This work was supported by The Netherlands Organization
for Scientific Research (NWO), under the auspices of the
Chemical Foundation (CW) and the Technology Foundation(STW, Grant 790.33.571).We thank Solvay Pharmaceuticals,
Weesp, The Netherlands for generous supplies of influenza
virus. Klaas Sjollema, Department of Eukaryotic Microbiology,
University of Groningen is acknowledged for excellent technical
help with electron microscopy experiments.
References
[1] J.D. Almeida, C.M. Brand, D.C. Edwards, T.D. Heath, Formation of
virosomes from influenza subunits and liposomes, Lancet 2 (1975) 899–901.
[2] S. Bagai, A. Puri, R. Blumenthal, D.P. Sarkar, Hemagglutinin-neuramin-
idase enhances F protein-mediated membrane fusion of reconstituted
Sendai virus envelopes with cells, J. Virol. 67 (1993) 3312–3318.
[3] T. Uchida, J. Kim, M. Yamaizumi, Y. Miyake, Y. Okada, Reconstitution of
lipid vesicles associated with HVJ (Sendai virus) spikes. Purification and
some properties of vesicles containing nontoxic fragment A of diphtheria
toxin, J. Cell Biol. 80 (1979) 10–20.
[4] A. Vainstein, M. Hershkovitz, S. Israel, S. Rabin, A. Loyter, A new method
for reconstitution of highly fusogenic Sendai virus envelopes, Biochim.
Biophys. Acta 773 (1984) 181–188.
[5] A. Helenius, M. Sarvas, K. Simons, Asymmetric and symmetric membrane
reconstitution by detergent elimination. Studies with Semliki-Forest-virus
spike glycoprotein and penicillinase from the membrane of Bacillus
licheniformis, Eur. J. Biochem. 116 (1981) 27–35.
[6] A. Helenius, E. Fries, J. Kartenbeck, Reconstitution of Semliki Forest virus
membrane, J Cell Biol. 75 (1977) 866–880.
[7] K. Metsikkö, G. van Meer, K. Simons, Reconstitution of the fusogenic
activity of vesicular stomatitis virus, EMBO J. 5 (1986) 3429–3435.
[8] W.A. Petri Jr., R.R. Wagner, Reconstitution into liposomes of the
glycoprotein of vesicular stomatitis virus by detergent dialysis, J. Biol.
Chem. 254 (1979) 4313–4316.
[9] R.K. Scheule, Novel preparation of functional Sindbis virosomes,
Biochemistry 25 (1986) 4223–4232.
[10] R. Glück, R. Mischler, B. Finkel, J.U. Que, B. Scarpa, S.J. Cryz Jr.,
Immunogenicity of new virosome influenza vaccine in elderly people,
Lancet 344 (1994) 160–163.
[11] A. Huckriede, L. Bungener, W. ter Veer, M. Holtrop, T. Daemen, A.M.
Palache, J. Wilschut, Influenza virosomes: combining optimal presentation
of hemagglutinin with immunopotentiating activity, Vaccine 21 (2003)
925–931.
[12] A. Huckriede, L. Bungener, T. Stegmann, T. Daemen, J. Medema, A.M.
Palache, J. Wilschut, The virosome concept for influenza vaccines,
Vaccine vol. 23 (Suppl. 1) (2005) S26–S38.
[13] T. Daemen, A. de Mare, L. Bungener, J. de Jonge, A. Huckriede, J.
Wilschut, Virosomes for antigen and DNA delivery, Adv. Drug Delivery
Rev. 57 (2005) 451–463.
[14] Y. Kaneda, Virosomes: evolution of the liposome as a targeted drug
delivery system, Adv. Drug Delivery Rev. 43 (2000) 197–205.
[15] D.P. Sarkar, K. Ramani, S.K. Tyagi, Targeted gene delivery by virosomes,
Methods Mol. Biol. 199 (2002) 163–173.
[16] D. Felnerova, J.F. Viret, R. Glück, C. Moser, Liposomes and virosomes as
delivery systems for antigens, nucleic acids and drugs, Curr. Opin.
Biotechnol. 15 (2004) 518–529.
[17] Q. Huang, Early steps of the conformational change of influenza virus
hemagglutinin to a fusion active state—Stability and energetics of the
hemagglutinin, Biochim. Biophys. Acta, Biomembr. 1614 (2003) 3–13.
[18] P.M. Colman, M.C. Lawrence, The structural biology of type I viral
membrane fusion, Nat. Rev., Mol. Cell Biol. 4 (2003) 309–319.
[19] L.J. Earp, S.E. Delos, H.E. Park, J.M. White, The many mechanisms of viral
membrane fusion proteins, Curr. Top.Microbiol. Immunol. 285 (2005) 25–66.
[20] T.S. Jardetzky,R.A.Lamb,Virology—Aclassact,Nature427(2004)307–308.
[21] A.E. Smith, A. Helenius, How viruses enter animal cells, Science 304
(2004) 237–242.
[22] T. Stegmann, H.W.M. Morselt, F.P. Booy, J.F.L. Van Breemen, G.
Scherphof, J. Wilschut, Functional reconstitution of influenza virus
envelopes, EMBO J. 6 (1987) 2651–2659.
536 J. de Jonge et al. / Biochimica et Biophysica Acta 1758 (2006) 527–536[23] P. Schoen, R. Bron, J. Wilschut, Delivery of foreign substances to cells
mediated by fusion-active reconstituted influenza virus envelopes (viro-
somes), J. Liposome Res. 3 (1993) 767–792.
[24] R. Bron, A. Ortiz, J. Wilschut, Cellular cytoplasmic delivery of a
polypeptide toxin by reconstituted influenza-virus envelopes (virosomes),
Biochemistry 33 (1994) 9110–9117.
[25] L. Bungener, K. Serre, L. Bijl, L. Leserman, J. Wilschut, T. Daemen, P.
Machy, Virosome-mediated delivery of protein antigens to dendritic cells,
Vaccine 20 (2002) 2287–2295.
[26] P. Schoen, A. Chonn, P.R. Cullis, J. Wilschut, P. Scherrer, Gene transfer
mediated by fusion protein hemagglutinin reconstituted in cationic lipid
vesicles, Gene Ther. 6 (1999) 823–832.
[27] J. de Jonge, M. Holtrop, J. Wilschut, A. Huckriede, Reconstituted
influenza virus envelopes as an efficient carrier system for cellular delivery
of small-interfering RNAs, Gene Ther. 13 (2006) 400–411.
[28] A. Arkema, A. Huckriede, P. Schoen, J. Wilschut, T. Daemen, Induction of
cytotoxic T lymphocyte activity by fusion-active peptide-containing
virosomes, Vaccine 18 (2000) 1327–1333.
[29] L. Bungener, A. Huckriede, A. de Mare, J. de Vries-Idema, J. Wilschut, T.
Daemen, Virosome-mediated delivery of protein antigens in vivo: efficient
induction of class I MHC-restricted cytotoxic T lymphocyte activity,
Vaccine 23 (2005) 1232–1241.
[30] R.J. Tausk, J. Karmiggelt, C. Oudshoorn, J.T. Overbeek, Physical chemical
studies of short-chain lecithin homologues: I. Influence of the chain length
of the fatty acid ester and of electrolytes on the critical micelle
concentration, Biophys. Chem. 1 (1974) 175–183.
[31] H. Hauser, Short-chain phospholipids as detergents, Biochim. Biophys.
Acta, Biomembr. 1508 (2000) 164–181.
[32] N.E. Gabriel, M.F. Roberts, Spontaneous formation of stable unilamellar
vesicles, Biochemistry 23 (1984) 4011–4015.
[33] J. Kessi, J.C. Poiree, E. Wehrli, R. Bachofen, G. Semenza, H. Hauser,
Short-chain phosphatidylcholines as superior detergents in solubilizing
membrane proteins and preserving biological activity, Biochemistry 33
(1994) 10825–10836.
[34] B.D. Shivanna, E.S. Rowe, Preservation of the native structure and
function of Ca2+-ATPase from sarcoplasmic reticulum: solubilization and
reconstitution by new short-chain phospholipid detergent 1,2-diheptanoyl-
sn-phosphatidylcholine, Biochem. J. 325 (1997) 533–542.
[35] D. Boffelli, F.E. Weber, S. Compassi, M. Werder, G. Schulthess, H.
Hauser, Reconstitution and further characterization of the cholesterol
transport activity of the small-intestinal brush border membrane,
Biochemistry 36 (1997) 10784–10792.
[36] N.A. Dencher, Spontaneous transmembrane insertion of membrane-
proteins into lipid vesicles facilitated by short-chain lecithins, Biochem-
istry 25 (1986) 1195–1200.
[37] G.L. Peterson, A simplification of the protein assay method of Lowry et al.
which is more generally applicable, Anal. Biochem. 83 (1977) 346–356.
[38] C.J.F. Böttcher, C.M. van Gent, C. Pries, A rapid and sensitive sub-micro
phosphorus determination, Anal. Chim. Acta 24 (1961) 203–204.
[39] E.G. Bligh, W.J. Dyer, A rapid method of total lipid extraction and
purification, Can. J. Biochem. Physiol. 37 (1959) 911–917.[40] J.S. Ellingson, W.E.M. Lands, Phospholipid reactivation of plasmalogen
metabolism, Lipids 3 (1968) 111–120.
[41] T. Stegmann, P. Schoen, R. Bron, J. Wey, I. Bartoldus, A. Ortiz, J.L. Nieva,
J. Wilschut, Evaluation of viral membrane-fusion assays—Comparison of
the octadecylrhodamine dequenching assay with the pyrene excimer assay,
Biochemistry 32 (1993) 11330–11337.
[42] R.A. Lamb, R.M. Krug, Orthomyxoviridae, in: D.M. Knipe, P.N. Howley
(Eds.), Fields Virology, 4th ed., Lippincott Williams and Wilkins,
Philadelphia, 2001, pp. 1487–1531.
[43] J. Ramalho-Santos, S. Nir, N. Düzgünes, A.P. de Carvalho, C. Lima Mda,
A common mechanism for influenza virus fusion activity and inactivation,
Biochemistry 32 (1993) 2771–2779.
[44] E.I. Budowsky, Y. Smirnov, S.F. Shenderovich, Principles of selective
inactivation of viral genome: VIII. The influence of beta-propiolactone on
immunogenic and protective activities of influenza virus, Vaccine 11 (1993)
343–348.
[45] G. Sofer, Virus inactivation in the 1990s—And into the 21st century. part 4,
culture media, biotechnology products, and vaccines, Biopharm Int. 16
(2003) 50–57.
[46] M. Paternostre, M. Viard, O. Meyer, M. Ghanam, M. Ollivon, R.
Blumenthal, Solubilization and reconstitution of vesicular stomatitis virus
envelope using octylglucoside, Biophys. J 72 (1997) 1683–1694.
[47] W. Jiskoot, T. Teerlink, E.C. Beuvery, D.J. Crommelin, Preparation of
liposomes via detergent removal from mixed micelles by dilution. The
effect of bilayer composition and process parameters on liposome
characteristics, Pharm. Weekbl. Sci. 8 (1986) 259–265.
[48] O. Zumbuehl, H.G. Weder, Liposomes of controllable size in the range of
40 to 180 nm by defined dialysis of lipid/detergent mixed micelles,
Biochim. Biophys. Acta 640 (1981) 252–262.
[49] M. Seras, M. Ollivon, K. Edwards, S. Lesieur, Reconstitution of non-ionic
monoalkyl amphiphile–cholesterol vesicles by dilution of lipids–octyl-
glucoside mixed micelles, Chem. Phys. Lipids 66 (1993) 93–109.
[50] J. Leng, S.U. Egelhaaf, M.E. Cates, Kinetics of the micelle-to-vesicle
transition: aqueous lecithin-bile salt mixtures, Biophys. J. 85 (2003)
1624–1646.
[51] M. Ollivon, O. Eidelman, R. Blumenthal, A. Walter, Micelle vesicle
transition of egg phosphatidylcholine and octyl glucoside, Biochemistry
27 (1988) 1695–1703.
[52] D.D.Lasic, Themechanismof vesicle formation,Biochem. J. 256 (1988) 1–11.
[53] J.M. Wrigglesworth, M.S. Wooster, J. Elsden, H.J. Danneel, Dynamics of
proteoliposome formation. Intermediate states during detergent dialysis,
Biochem. J. 246 (1987) 737–744.
[54] J.L. Rigaud, B. Pitard, D. Levy, Reconstitution of membrane proteins into
liposomes: application to energy-transducing membrane proteins, Bio-
chim. Biophys. Acta 1231 (1995) 223–246.
[55] M.H. Milsmann, R.A. Schwendener, H.G. Weder, The preparation of large
single bilayer liposomes by a fast and controlled dialysis, Biochim.
Biophys. Acta 512 (1978) 147–155.
[56] R. Peschka, T. Purmann, R. Schubert, Cross-flow filtration — An
improved detergent removal technique for the preparation of liposomes,
Int. J. Pharm. 162 (1998) 177–183.
